Please log in to see the full text of this API!

Bremelanotide
  • Synonyms: PT-141
  • ATC: G02CX05
  • Use: Lorem 
  • Chemical name: Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
  • Formula: Lorem ipsum dolor sit amet,
  • MW:1025.2 g/mol
  • CAS-RN:189691-06-3
  • InChI Key:FFHBJDQSGDNCIV-UHFFFAOYSA-N
  • InChI:InChI=1S/C50H68N14O10/c1-​3-​4-​16-​35(58-​29(2)​65)​43(67)​64-​41-​25-​42(66)​54-​20-​11-​10-​18-​37(49(73)​74)​60-​46(70)​39(23-​31-​26-​56-​34-​17-​9-​8-​15-​33(31)​34)​62-​44(68)​36(19-​12-​21-​55-​50(51)​52)​59-​45(69)​38(22-​30-​13-​6-​5-​7-​14-​30)​61-​47(71)​40(63-​48(41)​72)​24-​32-​27-​53-​28-​57-​32/h5-​9,​13-​15,​17,​26-​28,​35-​41,​56H,​3-​4,​10-​12,​16,​18-​25H2,​1-​2H3,​(H,​53,​57)​(H,​54,​66)​(H,​58,​65)​(H,​59,​69)​(H,​60,​70)​(H,​61,​71)​(H,​62,​68)​(H,​63,​72)​(H,​64,​67)​(H,​73,​74)​(H4,​51,​52,​55)

Substance Classes

Synthesis Path

  • Bremelanotide is a cyclic heptapeptide lactam analogue of α-melanocyte-stimulating-hormone (α-MSH) and active metabolite of Melanotan II.

Trade Names

Country Trade Name Vendor Annotation
USA Lorem Lorem
(wfm = withdrawn from market)

Formulations

  • Loremipsumdolorsitamet,consetetursadipscingelitr,seddiam

References

    • a) US 9 999 999 (Palatin Technologies; 17.6.2003; appl. 28.6.2000; USA-prior. 29.6.1999).
    • US 9 999 999 (Palatin Technologies; 21.9.2004; appl. 4.1.2002; USA-prior. 29.6.1999).
    • b) WO 9999 999999 (Lonza AG; 30.3.2006; appl. 20.9.2005; EP-prior. 20.9.2004).
    • WO 9999 999999 (Hybio Pharmaceuticals; 31.1.2019; appl. 21.11.2017; CN-prior. 26.7.2017).

  • Uses of Bremelanotide in therapy:

    • US 9 999 999 (Palatin Technologies; 31.5.2016; appl. 24.6.2014; USA-prior. 5.11.2012).
    • US 99 999 999 (Palatin Technologies; 14.5.2019; appl. 29.3.2018; USA-prior. 5.11.2012).

  • Pharmaceutical compositions and methods for delivery of Bremelanotide:

    • US 9999 9999999 (Noven Pharmaceuticals; 5.7.2018; appl. 28.12.2017; USA-prior. 29.12.2016).
Cookie-Einstellungen